Institutional Ownership
Generate Biomedicines Inc
CUSIP 370920100COM SHSQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
54
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Flagship Pioneering, LLC | 62.67M | $783.41M |
| 2 | Fmr LLC | 4.22M | $52.72M |
| 3 | Capital World Investors | 4.00M | $50.05M |
| 4 | Braidwell LP | 3.59M | $44.91M |
| 5 | Jpmorgan Chase & Co | 2.95M | $33.92M |
| 6 | Arch Venture Management, LLC | 1.94M | $24.31M |
| 7 | Harbourvest Partners LLC | 1.72M | $21.53M |
| 8 | Baker Bros. Advisors LP | 1.42M | $17.80M |
| 9 | Harvard Management Co Inc | 1.11M | $13.89M |
| 10 | Nvidia Corp | 833.3K | $10.42M |